25 false false false false false false false false false false true false false false false false false No description of principal activity 2024-12-01 Sage Accounts Production Advanced 2023 - FRS102_2023 1,529,399 1,034,000 66,611 1,100,611 428,788 495,399 xbrli:pure xbrli:shares iso4217:GBP 06343412 2024-12-01 2025-11-30 06343412 2025-11-30 06343412 2024-11-30 06343412 2023-12-01 2024-11-30 06343412 2024-11-30 06343412 2023-11-30 06343412 core:PlantMachinery 2024-12-01 2025-11-30 06343412 core:FurnitureFittings 2024-12-01 2025-11-30 06343412 core:MotorVehicles 2024-12-01 2025-11-30 06343412 bus:RegisteredOffice 2024-12-01 2025-11-30 06343412 bus:LeadAgentIfApplicable 2024-12-01 2025-11-30 06343412 bus:Director1 2024-12-01 2025-11-30 06343412 bus:Director2 2024-12-01 2025-11-30 06343412 bus:Director3 2024-12-01 2025-11-30 06343412 bus:Director4 2024-12-01 2025-11-30 06343412 bus:CompanySecretary1 2024-12-01 2025-11-30 06343412 core:NetGoodwill 2024-11-30 06343412 core:NetGoodwill 2025-11-30 06343412 core:PlantMachinery 2024-11-30 06343412 core:FurnitureFittings 2024-11-30 06343412 core:PlantMachinery 2025-11-30 06343412 core:FurnitureFittings 2025-11-30 06343412 core:MotorVehicles 2025-11-30 06343412 core:WithinOneYear 2025-11-30 06343412 core:WithinOneYear 2024-11-30 06343412 core:AfterOneYear 2025-11-30 06343412 core:AfterOneYear 2024-11-30 06343412 core:ShareCapital 2025-11-30 06343412 core:ShareCapital 2024-11-30 06343412 core:CapitalRedemptionReserve 2025-11-30 06343412 core:CapitalRedemptionReserve 2024-11-30 06343412 core:RetainedEarningsAccumulatedLosses 2025-11-30 06343412 core:RetainedEarningsAccumulatedLosses 2024-11-30 06343412 core:BetweenOneFiveYears 2025-11-30 06343412 core:BetweenOneFiveYears 2024-11-30 06343412 core:MoreThanFiveYears 2025-11-30 06343412 core:MoreThanFiveYears 2024-11-30 06343412 core:NetGoodwill 2024-12-01 2025-11-30 06343412 core:NetGoodwill 2024-11-30 06343412 core:PlantMachinery 2024-11-30 06343412 core:FurnitureFittings 2024-11-30 06343412 bus:SmallEntities 2024-12-01 2025-11-30 06343412 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 06343412 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 06343412 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 06343412 bus:FullAccounts 2024-12-01 2025-11-30
COMPANY REGISTRATION NUMBER: 06343412
Thornes Pharmacy Limited
Filleted Unaudited Financial Statements
For the year ended
30 November 2025
Thornes Pharmacy Limited
Financial Statements
Year ended 30 November 2025
Contents
Page
Officers and professional advisers
1
Accountant's report to the board of directors on the preparation of the unaudited statutory financial statements of Thornes Pharmacy Limited
2
Statement of financial position
3
Notes to the financial statements
5
Thornes Pharmacy Limited
Officers and Professional Advisers
The board of directors
Mr N J Thorne
Mr D W Fairclough
Mrs J Thorne
Mrs E M Fairclough
Company secretary
Mr N J Thorne
Registered office
2 Oldfield Road
Bocam Park
United Kingdom
CF35 5LJ
Accountants
Clay Shaw Thomas Ltd
2 Oldfield Road
Bocam Park
Bridgend
CF35 5LJ
Bankers
Lloyds Bank Plc
31 Queen St
Cardiff
CF10 2AG
Thornes Pharmacy Limited
Accountant's Report to the Board of Directors on the Preparation of the Unaudited Statutory Financial Statements of Thornes Pharmacy Limited
Year ended 30 November 2025
As described on the statement of financial position, the directors of the company are responsible for the preparation of the financial statements for the year ended 30 November 2025, which comprise the statement of financial position and the related notes. You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions we have compiled these financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to us.
Clay Shaw Thomas Ltd
2 Oldfield Road Bocam Park Bridgend CF35 5LJ
5 May 2026
Thornes Pharmacy Limited
Statement of Financial Position
30 November 2025
2025
2024
Note
£
£
£
Fixed assets
Intangible assets
5
428,788
495,399
Tangible assets
6
32,763
18,838
---------
---------
461,551
514,237
Current assets
Stocks
84,137
63,054
Debtors
7
583,778
570,065
Cash at bank and in hand
212,657
185,804
---------
---------
880,572
818,923
Creditors: amounts falling due within one year
8
768,807
692,378
---------
---------
Net current assets
111,765
126,545
---------
---------
Total assets less current liabilities
573,316
640,782
Creditors: amounts falling due after more than one year
9
571,370
656,328
Provisions
Taxation including deferred tax
8,191
4,709
---------
---------
Net liabilities
( 6,245)
( 20,255)
---------
---------
Capital and reserves
Called up share capital
4
4
Capital redemption reserve
1
1
Profit and loss account
( 6,250)
( 20,260)
-------
--------
Shareholders deficit
( 6,245)
( 20,255)
-------
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
Thornes Pharmacy Limited
Statement of Financial Position (continued)
30 November 2025
These financial statements were approved by the board of directors and authorised for issue on 5 May 2026 , and are signed on behalf of the board by:
Mr N J Thorne
Director
Company registration number: 06343412
Thornes Pharmacy Limited
Notes to the Financial Statements
Year ended 30 November 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 2 Oldfield Road, Bocam Park, CF35 5LJ, United Kingdom.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The directors have assessed whether there are any material uncertainties that may cast significant doubt about the company's ability to continue to adopt the going concern basis of accounting for a period of at least twelve months from the date when the financial statements are authorised for issue. In assessing whether the going concern assumption is appropriate, the directors have taken in to account all available information about the future conclude that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.
Revenue recognition
The turnover shown in the profit and loss account represents amounts receivable during the year, exclusive of Value Added Tax in line with the company's principal activity which is that of a chemists. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer, usually on despatch of the goods, the amount of revenue can be measured reliably, it is probable that the associated economic benefits will flow to the entity, and the costs incurred or to be incurred in respect of the transactions can be measured reliably. Revenue from the rendering of services is measured by reference to the stage of completion of the service transaction at the end of the reporting period provided that the outcome can be reliably estimated. When the outcome cannot be reliably estimated, revenue is recognised only to the extent that it is probable the expenses recognised will be recovered.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Foreign currencies
Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.
Operating leases
Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
Goodwill
-
20 years
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Plant and machinery
-
25% reducing balance
Fixtures and fittings
-
25% reducing balance
Motor vehicles
-
25% reducing balance
Equipment
-
33% straight line
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.
Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.
Defined contribution plans
The company operates a defined contribution scheme. The amount charged to the profit and loss account in respect of pension costs are the contributions payable in the year. Differences between contributions payable in the year and contributions actually paid are shown as either accruals or prepayments in the balance sheet.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 25 (2024: 23 ).
5. Intangible assets
Goodwill
£
Cost
At 1 December 2024 and 30 November 2025
1,529,399
------------
Amortisation
At 1 December 2024
1,034,000
Charge for the year
66,611
------------
At 30 November 2025
1,100,611
------------
Carrying amount
At 30 November 2025
428,788
------------
At 30 November 2024
495,399
------------
6. Tangible assets
Plant and machinery
Fixtures and fittings
Motor vehicles
Equipment
Total
£
£
£
£
£
Cost
At 1 December 2024
15,617
97,111
6,425
119,153
Additions
1,236
18,361
225
19,822
--------
--------
--------
-------
---------
At 30 November 2025
16,853
97,111
18,361
6,650
138,975
--------
--------
--------
-------
---------
Depreciation
At 1 December 2024
13,745
81,599
4,971
100,315
Charge for the year
545
3,878
383
1,091
5,897
--------
--------
--------
-------
---------
At 30 November 2025
14,290
85,477
383
6,062
106,212
--------
--------
--------
-------
---------
Carrying amount
At 30 November 2025
2,563
11,634
17,978
588
32,763
--------
--------
--------
-------
---------
At 30 November 2024
1,872
15,512
1,454
18,838
--------
--------
--------
-------
---------
7. Debtors
2025
2024
£
£
Trade debtors
520,542
503,779
Amounts owed by group undertakings
8,098
8,059
Other debtors
55,138
58,227
---------
---------
583,778
570,065
---------
---------
8. Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans and overdrafts
86,810
86,727
Trade creditors
320,843
303,295
Social security and other taxes
121,618
68,257
Other creditors
239,536
234,099
---------
---------
768,807
692,378
---------
---------
9. Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
571,370
656,328
---------
---------
Included within creditors: amounts falling due after more than one year is an amount of £224,582 (2024: £325,549) in respect of liabilities payable or repayable by instalments which fall due for payment after more than five years from the reporting date.
The loans are secured by a debenture and by a fixed and floating charge over the company's assets.
10. Operating leases
The total future minimum lease payments under non-cancellable operating leases are as follows:
2025
2024
£
£
Not later than 1 year
49,500
55,547
Later than 1 year and not later than 5 years
198,000
198,000
Later than 5 years
601,083
650,583
---------
---------
848,583
904,130
---------
---------
11. Related party transactions
The company has taken exemption from disclosing related party transactions with wholly owned companies within a group. The company has also taken exemption under the small companies regime from disclosing related party transactions that are either considered immaterial or concluded under normal market conditions.